Cited by 147Respiratory viral infections researchSARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections Studies

The DOI matches its Crossref record; 20 of the 22 references it cites were found in a registry or an index.

The behaviour of recent isolates of human respiratory coronavirus in vitro and in volunteers: evidence of heterogeneity among 229E-related strains

Open access

Reed, Sylvia E.·1984·Journal of Medical Virology

DOI 10.1002/jmv.1890130208PMC PMC7166702

Open this paper in CoChat — free account Open PDF

Abstract

Strains of human coronavirus (HCV) isolated between 1974 and 1976 have been studied in vitro and in volunteers. All strains caused colds in volunteers, and those cultivable in tissue culture (TC) produced significantly more coryza and less sore throat than strains growing only in organ culture (OC). The TC strains were serologically related to 229E, but these isolates produced colds with a frequency and severity that contrasted with the effects of 229E itself. Tests on volunteers' preinfection sera showed that the prevalence of antibody to 229E had increased during the period 1961–1979 and that during 1977–1979 only 11% of subjects had no neutralising antibody against 229E. Susceptibility to the 229E‐related isolates PR and TO was associated with low preinfection serum neutralising antibody against the homologous virus, and paired sera frequently showed fourfold or greater antibody rises, most commonly against the homologous strain. Volunteers infected with TO were immune when reinoculated with the same strain approximately 1 year later, but other similar volunteers were at least partly susceptible to infection with a heterologous 229E‐related virus after similar time intervals. Although the strains of HCV that were grown in tissue culture were all related to the prototype 229E, they appeared not to be identical with it, and this heterogeneity is probably a significant factor in the epidemiology of HCV infections.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1002/jmv.1890130208

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A New Virus Isolated from the Human Respiratory Tract.
Hamre, D. M., & Procknow, J. J. (1966) · Experimental Biology and Medicine · doi:10.3181/00379727-121-30734 · Cited by 888
Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease.
McIntosh, K., Dees, J. H., Becker, W. B., Kapikian, A. Z., & Chanock, R. M. (1967) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.57.4.933 · Cited by 589
Effects of a "new" human respiratory virus in volunteers.
Bradburne, A. F., Bynoe, M. L., & Tyrrell, D. A. J. (1967) · BMJ · doi:10.1136/bmj.3.5568.767 · Cited by 304
The Morphology of Three Previously Uncharacterized Human Respiratory Viruses that Grow in Organ Culture
Almeida, J. D., & Tyrrell, D. A. J. (1967) · Journal of General Virology · doi:10.1099/0022-1317-1-2-175 · Cited by 275
Coronaviruses: A Comparative Review
McIntosh, K. (1974) · Springer eBooks · doi:10.1007/978-3-642-65775-7_3 · Cited by 270
Isolation of rhinoviruses and coronaviruses from 38 colds in adults
Larson, H. E., Reed, S. E., & Tyrrell, D. A. J. (1980) · Journal of Medical Virology · doi:10.1002/jmv.1890050306 · Cited by 168
Self-citation
The Structure and Replication of Coronaviruses
Siddell, S. G., Wege, H., & ter Meulen, V. (1982) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-68528-6_4 · Cited by 136
Taxonomic studies on strains of avian infectious bronchitis virus using neutralisation tests in tracheal organ cultures
Darbyshire, J. H., Rowell, J. G., Cook, J. K. A., & Peters, R. W. (1979) · Archives of Virology · doi:10.1007/bf01318057 · Cited by 133
Coronavirus infections in working adults. Eight-year study with 229 E and OC 43.
Hendley, J. O., Fishburne, H. B., & Gwaltney, J. M. (1972) · PubMed · doi:10.1164/arrd.1972.105.5.805 · Cited by 118
Medical reviews. Coronaviruses.
Monto, A. S. (1974) · PubMed Central · Cited by 98

Show all 22 references

Research works printed but not linked: 1

Hendley JO, 1972, Coronavirus infections in working adults: Eight year study with 229E and OC43, American Review of Respiratory Disease, 105, 805

Sorted by citations

Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody
Pinto, D., Park, Y.-J., Beltramello, M., Walls, A. C., Tortorici, M. A., Bianchi, S., Jaconi, S., Culap, K., Zatta, F., De Marco, A., et al. (2020) · Nature · doi:10.1038/s41586-020-2349-y · Cited by 1,885
Adaptive immunity to SARS-CoV-2 and COVID-19
Sette, A., & Crotty, S. (2021) · Cell · doi:10.1016/j.cell.2021.01.007 · Cited by 1,860
Immunology of COVID-19: Current State of the Science
Vabret, N., Britton, G. J., Gruber, C., Hegde, S., Kim, J., Kuksin, M., Levantovsky, R., Malle, L., Moreira, A., Park, M. D., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.05.002 · Cited by 1,623
Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays
Crawford, K. H. D., Eguia, R. T., Dingens, A. S., Loes, A. N., Malone, K. D., Wolf, C. R., Chu, H. Y., Tortorici, M. A., Veesler, D., Murphy, M., et al. (2020) · Viruses · doi:10.3390/v12050513 · Cited by 744
Seasonal coronavirus protective immunity is short-lasting
Edridge, A. W. D., Kaczorowska, J., Hoste, A. C. R., Bakker, M., Klein, M., Loens, K., Jebbink, M. F., Matser, A., Kinsella, C. M., Rueda, P., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1083-1 · Cited by 767
Genomic evidence for reinfection with SARS-CoV-2: a case study
Tillett, R. L., Sevinsky, J. R., Hartley, P. D., Kerwin, H., Crawford, N. F., Gorzalski, A. J., Laverdure, C., Verma, S. C., Rossetto, C. C., Jackson, D. K., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30764-7 · Cited by 755
A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity
Huang, A. T., Garcia-Carreras, B., Hitchings, M. D. T., Yang, B., Katzelnick, L. C., Rattigan, S. M., Borgert, B. A., Moreno, C. A., Solomon, B. D., Trimmer-Smith, L., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18450-4 · Cited by 1,026
A decade after SARS: strategies for controlling emerging coronaviruses
Graham, R. L., Donaldson, E., & Baric, R. S. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro3143 · Cited by 689
The time course of the immune response to experimental coronavirus infection of man
Callow, K. A., Parry, H. F., Sergeant, M., & Tyrrell, D. A. J. (1990) · Epidemiology and Infection · doi:10.1017/s0950268800048019 · Cited by 598
Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults
Killingley, B., Mann, A., Kalinova, M., Boyers, A., Goonawardane, N., Zhou, J., Lindsell, K., Hare, S. S., Brown, J. C., Frise, R., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01780-9 · Cited by 532
A perspective on potential antibody-dependent enhancement of SARS-CoV-2
Arvin, A. M., Fink, K., Schmid, M. A., Cathcart, A., Spreafico, R., Havenar-Daughton, C., Lanzavecchia, A., Corti, D., & Virgin, H. W. (2020) · Nature · doi:10.1038/s41586-020-2538-8 · Cited by 485
Bat origin of human coronaviruses
Hu, B., Ge, X., Wang, L., & Shi, Z. (2015) · Virology Journal · doi:10.1186/s12985-015-0422-1 · Cited by 507
Novel human coronavirus (SARS-CoV-2): A lesson from animal coronaviruses
Decaro, N., & Lorusso, A. (2020) · Veterinary Microbiology · doi:10.1016/j.vetmic.2020.108693 · Cited by 384
Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison
Ainsworth, M. A., Andersson, M. I., Auckland, K., Baillie, J. K., Barnes, E. J., Beer, S., Beveridge, A., Bibi, S., Blackwell, L., Borak, M., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30634-4 · Cited by 341
The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection
Kellam, P., & Barclay, W. (2020) · Journal of General Virology · doi:10.1099/jgv.0.001439 · Cited by 353
Orthogonal SARS-CoV-2 Serological Assays Enable Surveillance of Low-Prevalence Communities and Reveal Durable Humoral Immunity
Ripperger, T. J., Uhrlaub, J. L., Watanabe, M., Wong, R., Castaneda, Y., Pizzato, H. A., Thompson, M. R., Bradshaw, C. M., Weinkauf, C. C., Bime, C., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.10.004 · Cited by 338
Molecular pathology of emerging coronavirus infections
Gralinski, L. E., & Baric, R. S. (2014) · The Journal of Pathology · doi:10.1002/path.4454 · Cited by 326
The Novel Human Coronaviruses NL63 and HKU1
Pyrć, K., Berkhout, B., & van der Hoek, L. (2007) · Journal of Virology · doi:10.1128/jvi.01466-06 · Cited by 267
Cross-reactive memory T cells and herd immunity to SARS-CoV-2
Lipsitch, M., Grad, Y. H., Sette, A., & Crotty, S. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-00460-4 · Cited by 260
A human coronavirus evolves antigenically to escape antibody immunity
(2021) · doi:10.1371/journal.ppat.1009453 · Cited by 258
A human coronavirus evolves antigenically to escape antibody immunity
Eguia, R., Crawford, K. H. D., Stevens-Ayers, T., Kelnhofer-Millevolte, L., Greninger, A. L., Englund, J. A., Boeckh, M. J., & Bloom, J. D. (2020) · doi:10.1101/2020.12.17.423313 · Cited by 258
Human coronavirus NL63, a new respiratory virus
van der Hoek, L., Pyrć, K., & Berkhout, B. (2006) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2006.00032.x · Cited by 217
Human Coronavirus NL63 and 229E Seroconversion in Children
Dijkman, R., Jebbink, M. F., Idrissi, N. B. E., Pyrć, K., Müller, M. A., Kuijpers, T. W., Zaaijer, H. L., & van der Hoek, L. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00533-08 · Cited by 180
Immunity to SARS‐CoV‐2 induced by infection or vaccination
Dopico, X. C., Ols, S., Loré, K., & Hedestam, G. B. K. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13372 · Cited by 172
Isolation and Characterization of Current Human Coronavirus Strains in Primary Human Epithelial Cell Cultures Reveal Differences in Target Cell Tropism
Dijkman, R., Jebbink, M. F., Koekkoek, S. M., Deijs, M., Jónsdóttir, H. R., Molenkamp, R., Ieven, M. M., Goossens, H., Thiel, V., & van der Hoek, L. (2013) · Journal of Virology · doi:10.1128/jvi.03368-12 · Cited by 155
Replication-dependent downregulation of cellular angiotensin-converting enzyme 2 protein expression by human coronavirus NL63
Dijkman, R., Jebbink, M. F., Deijs, M., Milewska, A., Pyrć, K., Buelow, E., van der Bijl, A., & van der Hoek, L. (2012) · Journal of General Virology · doi:10.1099/vir.0.043919-0 · Cited by 138
Persistent Infection of Human Oligodendrocytic and Neuroglial Cell Lines by Human Coronavirus 229E
Arbour, N., Ékandé, S., Côté, G., Lachance, C., Chagnon, F., Tardieu, M., Cashman, N. R., & Talbot, P. J. (1999) · Journal of Virology · doi:10.1128/jvi.73.4.3326-3337.1999 · Cited by 133
The common cold: a review of the literature
Wat, D. (2004) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2004.01.006 · Cited by 125
COVID-19: Mechanisms of Vaccination and Immunity
Speiser, D. E., & Bachmann, M. F. (2020) · Vaccines · doi:10.3390/vaccines8030404 · Cited by 130
How to detect and reduce potential sources of biases in studies of SARS-CoV-2 and COVID-19
Accorsi, E. K., Qiu, X., Rumpler, É., Kennedy‐Shaffer, L., Kahn, R. J., Joshi, K., Goldstein, E., Stensrud, M. J., Niehus, R., Çevik, M., et al. (2021) · European Journal of Epidemiology · doi:10.1007/s10654-021-00727-7 · Cited by 128
Recently Discovered Human Coronaviruses
Wevers, B. A., & van der Hoek, L. (2009) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2009.07.007 · Cited by 127
SARS-CoV-2 seroprevalence in COVID-19 hotspots
Eckerle, I., & Meyer, B. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31482-3 · Cited by 119
Effect of specific humoral immunity and some non-specific factors on resistance of volunteers to respiratory coronavirus infection
Callow, K. A. (1985) · Journal of Hygiene · doi:10.1017/s0022172400062410 · Cited by 119
Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1–2, dose-ranging study
Goepfert, P., Fu, B., Chabanon, A.-L., Bonaparte, M. I., Davis, M., Essink, B. J., Frank, I., Haney, O., Janosczyk, H., Keefer, M. C., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(21)00147-x · Cited by 114
Receptor-binding loops in alphacoronavirus adaptation and evolution
Wong, A. H. M., Tomlinson, A. C. A., Zhou, D., Satkunarajah, M., Chen, K., Sharon, C., Desforges, M., Talbot, P. J., & Rini, J. M. (2017) · Nature Communications · doi:10.1038/s41467-017-01706-x · Cited by 110
Identification of new human coronaviruses
Pyrć, K., Berkhout, B., & van der Hoek, L. (2007) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.5.2.245 · Cited by 111
Coronaviruses and the human airway: a universal system for virus-host interaction studies
Jónsdóttir, H. R., & Dijkman, R. (2016) · Virology Journal · doi:10.1186/s12985-016-0479-5 · Cited by 99
The immunology of SARS-CoV-2 infections and vaccines
Grigoryan, L., & Pulendran, B. (2020) · Seminars in Immunology · doi:10.1016/j.smim.2020.101422 · Cited by 102
The “Common Cold” in Frail Older Persons: Impact of Rhinovirus and Coronavirus in a Senior Daycare Center
Falsey, A. R., McCann, R. M., Hall, W. J., Criddle, M. M., Formica, M. A., Wycoff, D., & Kolassa, J. E. (1997) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1997.tb01474.x · Cited by 95
Evidence for adaptive evolution in the receptor-binding domain of seasonal coronaviruses OC43 and 229e
Kistler, K. E., & Bedford, T. (2021) · eLife · doi:10.7554/elife.64509 · Cited by 94
Prevention of Experimental Coronavirus Colds with Intranasal -2b Interferon
Turner, R. B., Felton, A., Kosak, K. M., Kelsey, D. K., & Meschievitz, C. (1986) · The Journal of Infectious Diseases · doi:10.1093/infdis/154.3.443 · Cited by 91
Antibody Responses to SARS-CoV-2: Let’s Stick to Known Knowns
Baumgarth, N., Nikolich-Žugich, J., Lee, F. E.-H., & Bhattacharya, D. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000839 · Cited by 84
Respiratory viral infections in the elderly
Treanor, J. J., & Falsey, A. R. (1999) · Antiviral Research · doi:10.1016/s0166-3542(99)00062-5 · Cited by 88
COVID-19 Vaccines: “Warp Speed” Needs Mind Melds, Not Warped Minds
Moore, J. P., & Klasse, P. J. (2020) · Journal of Virology · doi:10.1128/jvi.01083-20 · Cited by 87
Human Coronavirus Infections
Myint, S. (1995) · Springer eBooks · doi:10.1007/978-1-4899-1531-3_18 · Cited by 80
Seasonality and immunity to laboratory-confirmed seasonal coronaviruses (HCoV-NL63, HCoV-OC43, and HCoV-229E): results from the Flu Watch cohort study
Aldridge, R. W., Lewer, D., Beale, S., Johnson, A. M., Zambon, M. C. F. A., Hayward, A. C., Fragaszy, E., & Flu Watch Group (2020) · Wellcome Open Research · doi:10.12688/wellcomeopenres.15812.2 · Cited by 71
Detection and quantification of infectious severe acute respiratory coronavirus-2 in diverse clinical and environmental samples
Lin, Y.-C., Malott, R. J., Ward, L., Kiplagat, L., Pabbaraju, K., Gill, K., Berenger, B. M., Hu, J., Fonseca, K., Noyce, R. S., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-09218-5 · Cited by 74
Instructing durable humoral immunity for COVID-19 and other vaccinable diseases
Bhattacharya, D. (2022) · Immunity · doi:10.1016/j.immuni.2022.05.004 · Cited by 64
Coronavirus Pneumonia Following Autologous Bone Marrow Transplantation for Breast Cancer
Folz, R. J., & Elkordy, M. (1999) · CHEST Journal · doi:10.1378/chest.115.3.901 · Cited by 68
A Brief Review on the Possible Role of Houseflies and Cockroaches in the Mechanical Transmission of Coronavirus Disease 2019 (COVID-19)
Dehghani, R., & Kassiri, H. (2020) · Archives of Clinical Infectious Diseases · doi:10.5812/archcid.102863 · Cited by 66
Durability of Immunity to SARS-CoV-2 and Other Respiratory Viruses
Siggins, M. K., Thwaites, R. S., & Openshaw, P. (2021) · Trends in Microbiology · doi:10.1016/j.tim.2021.03.016 · Cited by 61
The Common Cold
Turner, R. B. (1998) · Pediatric Annals · doi:10.3928/0090-4481-19981201-06 · Cited by 61
SARS-CoV-2 structural features may explain limited neutralizing-antibody responses
Bachmann, M. F., Mohsen, M. O., Zha, L., Vogel, M., & Speiser, D. E. (2021) · npj Vaccines · doi:10.1038/s41541-020-00264-6 · Cited by 59
Polymyalgia, Hypersensitivity Pneumonitis and Other Reactions in Patients Receiving HMG-CoA Reductase Inhibitors
Liebhaber, M. I., Wright, R. S., Gelberg, H. J., Dyer, Z. A., & Kupperman, J. (1999) · CHEST Journal · doi:10.1378/chest.115.3.886 · Cited by 54
Viral pneumonia in children
Henrickson, K. J. (1998) · Seminars in Pediatric Infectious Diseases · doi:10.1016/s1045-1870(98)80035-6 · Cited by 53
Epidemiology of Viral Respiratory Tract Infections
Johnston, S. L., & Holgate, S. T. (1996) · Springer eBooks · doi:10.1007/978-94-011-7930-0_1 · Cited by 46
SARS-CoV-2 antibody testing for estimating COVID-19 prevalence in the population
Vogl, T. J., Leviatan, S., & Segal, E. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100191 · Cited by 44
Immunological and physiopathological approach of COVID-19 in pregnancy
Ferrer‐Oliveras, R., Mendoza, M., Capote, S., Pratcorona, L., Esteve‐Valverde, E., Cabero, L., & Alijotas‐Reig, J. (2021) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-021-06061-3 · Cited by 46
Potential Biases Arising From Epidemic Dynamics in Observational Seroprotection Studies
Kahn, R. J., Kennedy‐Shaffer, L., Grad, Y. H., Robins, J. M., & Lipsitch, M. (2020) · American Journal of Epidemiology · doi:10.1093/aje/kwaa188 · Cited by 40
The SARS-CoV-2 pandemic: remaining uncertainties in our understanding of the epidemiology and transmission dynamics of the virus, and challenges to be overcome
Anderson, R. M., Vegvari, C., Hollingsworth, T. D., Pi, L., Maddren, R., Ng, C. W., & Baggaley, R. F. (2021) · Interface Focus · doi:10.1098/rsfs.2021.0008 · Cited by 38
Protective Immunity against SARS Subunit Vaccine Candidates Based on Spike Protein: Lessons for Coronavirus Vaccine Development
Khalaj‐Hedayati, A. (2020) · Journal of Immunology Research · doi:10.1155/2020/7201752 · Cited by 35
Longitudinal SARS‐CoV‐2 seroprevalence in Portugal and antibody maintenance 12 months after infection
Castro, L. C. E., Gomes, A., Serrano, M., Pereira, A. H. G., Ribeiro, R., Napoleão, P., Domingues, I., Silva, C., Fanczal, J., Afonso, Â., et al. (2021) · European Journal of Immunology · doi:10.1002/eji.202149619 · Cited by 30
Cross-Reactive Immune Responses toward the Common Cold Human Coronaviruses and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Mini-Review and a Murine Study
Sealy, R. E., & Hurwitz, J. L. (2021) · Microorganisms · doi:10.3390/microorganisms9081643 · Cited by 30
Coronaviruses
Monto, A. S., Cowling, B. J., & Peiris, M. J. S. (2014) · Springer eBooks · doi:10.1007/978-1-4899-7448-8_10 · Cited by 27
How immunity from and interaction with seasonal coronaviruses can shape SARS-CoV-2 epidemiology
Waterlow, N. R., van Leeuwen, E., Davies, N. G., CMMID COVID-19 Working Group, Flasche, S., & Eggo, R. M. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2108395118 · Cited by 26
Immunity and infectivity in covid-19
Johnston, C., Hughes, H. C., Lingard, S., Hailey, S., & Healy, B. (2022) · BMJ · doi:10.1136/bmj-2020-061402 · Cited by 24
Human Challenge Studies: A Review of Adequacy of Reporting Methods and Results
Kalil, J. A., Halperin, S. A., & Langley, J. M. (2012) · Future Microbiology · doi:10.2217/fmb.12.15 · Cited by 21
Animal Models of COVID-19 II. Comparative Immunology
Veenhuis, R. T., & Zeiss, C. J. (2021) · ILAR Journal · doi:10.1093/ilar/ilab010 · Cited by 21
Coronaviruses
McIntosh, K., & Peiris, M. J. S. (2009) · Wiley eBooks · doi:10.1128/9781555815981.ch51 · Cited by 19
High-throughput quantitation of SARS-CoV-2 antibodies in a single-dilution homogeneous assay
Kainulainen, M. H., Bergeron, É., Chatterjee, P., Chapman, A. P., Lee, J. S., Chida, A. S., Tang, X., Wharton, R. E., Mercer, K. B., Petway, M., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-91300-5 · Cited by 18
Two-tiered SARS-CoV-2 seroconversion screening in the Netherlands and stability of nucleocapsid, spike protein domain 1 and neutralizing antibodies
Garritsen, A., Scholzen, A., van den Nieuwenhof, D. W. A., Smits, A. P. F., Datema, E. S., van Galen, L. S., & Kouwijzer, M. (2021) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2021.1893378 · Cited by 15
Optimizing human coronavirus OC43 growth and titration
Savoie, C. J., & Lippé, R. (2022) · PeerJ · doi:10.7717/peerj.13721 · Cited by 16
Immunology of SARS-CoV-2 infections and vaccines
Schenten, D., & Bhattacharya, D. (2021) · Advances in immunology · doi:10.1016/bs.ai.2021.08.002 · Cited by 14
Exploring human-animal host interactions and emergence of COVID-19: Evolutionary and ecological dynamics
Perveen, N., Muzaffar, S. B., & Al-Deeb, M. A. (2020) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2020.11.077 · Cited by 17
An Insight Into COVID-19: A 21st Century Disaster and Its Relation to Immunocompetence and Food Antioxidants
Siddique, F., Abbas, R. Z., Mansoor, M. K., Al-Ghamdi, E. S., Saeed, M., Ayaz, M., Rahman, M., Mahmood, M. S., Iqbal, A., Manzoor, M., et al. (2021) · Frontiers in Veterinary Science · doi:10.3389/fvets.2020.586637 · Cited by 14
A Comprehensive Analysis of Maternal and Newborn Disease and Related Control for COVID-19
Cimolai, N. (2021) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-021-00836-0 · Cited by 14
Severe Acute Respiratory Syndrome – a New Coronavirus from the Chinese Dragon's Lair*
Knudsen, T. B., Kledal, T. N., Andersen, O., Eugen‐Olsen, J., & Kristiansen, T. B. (2003) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.2003.01302.x · Cited by 14
Coronaviruses
Peiris, M. J. S. (2016) · ASM Press eBooks · doi:10.1128/9781555819439.ch52 · Cited by 13
Viral Infections
Lee, F. E.-H., & Treanor, J. J. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-3383-5.00032-4 · Cited by 14
Coronaviridae: The Coronaviruses
Hierholzer, J. C., & Tannock, G. A. (1988) · Springer eBooks · doi:10.1007/978-1-4612-3900-0_24 · Cited by 13
The Common Cold
Turner, R. B. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00058-8 · Cited by 15
Applying Immune Instincts and Maternal Intelligence from Comparative Microbiology to COVID-19
Cimolai, N. (2020) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-020-00634-0 · Cited by 11
COVID-19 and SARS-CoV-2: Everything we know so far – A comprehensive review
Naz, S., Zahoor, M., Sahibzada, M. U. K., Ullah, R., & Alqahtani, A. S. (2021) · Open Chemistry · doi:10.1515/chem-2021-0049 · Cited by 14
Comparison of the humoral and cellular immunity in COVID-19 convalescents
Топтыгина, А. П., Semikina, E. L., Шакирович, З. Р., & Afridonova, Z. E. (2022) · Russian Journal of Infection and Immunity · doi:10.15789/2220-7619-cot-1809 · Cited by 12
First molecular detection of SARS-CoV-2 virus in cockroaches
Kalantari, M., Vahedi, M., Azizi, K., Hosseinpour, A., Jamalidoust, M., Rezanezhad, H., Alipour, H., Miri, M., abolhasanbeigi, N., & Ashraf, H. (2023) · Biologia · doi:10.1007/s11756-023-01332-7 · Cited by 11
COVID-19 vaccine and boosted immunity: Nothing ad interim to do?
Roncati, L., Vadalà, M., Corazzari, V., & Palmieri, B. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.10.013 · Cited by 10
Evidence for adaptive evolution in the receptor-binding domain of seasonal coronaviruses OC43 and 229EPreprint
Kistler, K. E., & Bedford, T. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.10.30.352914 · Cited by 14
SARS-CoV-2 Vaccines: ‘Warp Speed’ Needs Mind Melds not Warped Minds
Moore, J. P., & Klasse, P. J. (2020) · Cited by 9
Diagnostic Value of IgM and IgG Detection in COVID-19 Diagnosis by the Mobile Laboratory B-LiFE: A Massive Testing Strategy in the Piedmont Region
Nyabi, O., Bentahir, M., Ambroise, J., Bearzatto, B., Chibani, N., Smits, B., Durant, J., Vybornov, A., Thellin, O., Moualij, B. E., et al. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18073372 · Cited by 9
How to detect and reduce potential sources of biases in epidemiologic studies of SARS-CoV-2Preprint
Accorsi, E. K., Qiu, X., Rumpler, É., Kennedy‐Shaffer, L., Kahn, R. J., Joshi, K., Goldstein, E., Stensrud, M. J., Niehus, R., Çevik, M., et al. (2020) · doi:10.31219/osf.io/46am5 · Cited by 9
A Minimalist Strategy Towards Temporarily Defining Protection for COVID-19
Cimolai, N. (2020) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-020-00533-4 · Cited by 8
Features of humoral immunity after COVID-19
Semenova, E. V., Pavliuk, V. V., Uvarova, M. A., & Иванов, А. В. (2022) · Medical Immunology (Russia) · doi:10.15789/1563-0625-foh-2452 · Cited by 11
An ethical analysis of vaccinating children against COVID-19: benefits, risks, and issues of global health equity
Gur‐Arie, R., Kraaijeveld, S. R., & Jamrozik, E. (2021) · Wellcome Open Research · doi:10.12688/wellcomeopenres.17234.1 · Cited by 8
‘Vivaldi’: an amplicon-based whole-genome sequencing method for the four seasonal human coronaviruses, 229E, NL63, OC43 and HKU1, alongside SARS-CoV-2
McClure, C. P., Tsoleridis, T., Hill, J. D., Holmes, N., Chappell, J. G., Byaruhanga, T., Duncan, J. D., Tofan, M., Berry, L., Clark, G., et al. (2025) · Microbial Genomics · doi:10.1099/mgen.0.001451 · Cited by 8
Coronavirus 229E with Rhinovirus co-infection causing severe acute respiratory distress syndrome with thrombotic microangiopathy and death during Covid-19 pandemic: lessons to be learnt
Daisley, H., Rampersad, A., Daisley, M., Ramdin, A., & Acco, O. (2020) · Autopsy and Case Reports · doi:10.4322/acr.2020.194 · Cited by 7
SARS-COV-2, can you be over it?
Fiocchi, A., & Jensen-Jarolim, E. (2021) · The World Allergy Organization Journal · doi:10.1016/j.waojou.2021.100514 · Cited by 6
Estimating the duration of seropositivity of human seasonal coronaviruses using seroprevalence studies
Rees, E. M., Waterlow, N. R., Lowe, R., & Kucharski, A. J. (2021) · Wellcome Open Research · doi:10.12688/wellcomeopenres.16701.1 · Cited by 8
The COVID-19 Pandemic—A Potential Role for Antivirals in Mitigating Pandemics
Neumann, G., & Kawaoka, Y. (2023) · Viruses · doi:10.3390/v15020303 · Cited by 6
Dose-response modelling of endemic coronavirus and SARS-CoV-2: human challenge trials reveal the individual variation in susceptibilityPreprint
Miura, F., Klinkenberg, D., & Wallinga, J. (2022) · medRxiv · doi:10.1101/2022.04.07.22273549 · Cited by 7
Seroprevalence and immunological memory against SARS-CoV-2 in lung cancer patients: the SOLID study
Provencio, M., Rodríguez‐Abreu, D., Granados, A. L. O., Serrano, G., Aguado, C., Franco, F., Gutiérrez, V., López-Vivanco, G., Guirado, M., Benítez, G., et al. (2021) · Translational Lung Cancer Research · doi:10.21037/tlcr-21-504 · Cited by 5

Authors: Reed, S. E.
Affiliations: Medical Research Council (GB)
Corresponding author: Reed, Sylvia E.
Venue: Journal of Medical Virology
Publisher: Wiley
Published: 1984-01
Volume: 13
Issue: 2
Pages: 179-192
ISSN: 0146-6615 (ISSN-L)
1096-9071
DOI: 10.1002/jmv.1890130208
PMC: PMC7166702
OpenAlex: W2029391755
Cited by: 147
References: 22
Citations by year: 2026: 2 · 2025: 4 · 2024: 6 · 2023: 5 · 2022: 11 · 2021: 36 · 2020: 36 · 2017: 1 · 2016: 2 · 2015: 4 · 2014: 2 · 2013: 2 · 2012: 4
FWCI: 1.28
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 8010 d)
Locations: Journal of Medical Virology (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
Keywords: 229E, cold, serological relatedness, neutralizing antibodies, antibody response, reinfection
MeSH terms: Adolescent, Adult, Antibodies, Viral, Antigens, Viral, Cell Line, Common Cold, Coronaviridae, Coronaviridae Infections, Humans, Middle Aged, Neutralization Tests, Viral Plaque Assay

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The behaviour of recent isolates of human respiratory coronavirus in vitro and in volunteers: evidence of heterogeneity among 229E-related strains

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks